Daewon Pharmaceutical Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-4,380	-1,380	14,210	23,917	31,944	6,989
Depreciation & Amortization	24,479	23,747	20,095	17,561	19,368	17,805
Loss (Gain) From Sale of Assets	1,907	2,091	-25.42	-149.95	-45.71	0.86
Asset Writedown & Restructuring Costs	942.29	1,240	4,671	4,597	2,154	1,111
Loss (Gain) From Sale of Investments	-11,135	-10,788	1,149	61.5	752.76	870.39
Loss (Gain) on Equity Investments	-900.4	-762.1	-704.2	-509.42	-860.08	-382.62
Provision & Write-off of Bad Debts	348.89	197.33	-204.13	230.88	887.59	-250.26
Other Operating Activities	10,658	9,396	17,840	10,638	13,240	13,054
Change in Accounts Receivable	-3,483	-3,963	-2,504	-7,949	-11,075	-11,278
Change in Inventory	12,836	14,168	-6,642	-15,837	-23,989	-4,075
Change in Accounts Payable	2,397	10,068	1,041	938.61	2,107	-1,445
Change in Income Taxes	1.18	1.32	3.21	-2.03	5.05	-0.32
Change in Other Net Operating Assets	10,074	-1,909	-18,894	18,239	-8,075	14.07
Operating Cash Flow	43,950	42,313	30,035	51,734	26,413	22,413
Operating Cash Flow Growth	-0.42%	40.88%	-41.94%	95.86%	17.85%	-10.17%
Capital Expenditures	-30,798	-29,801	-34,864	-12,289	-8,009	-4,104
Sale of Property, Plant & Equipment	476.52	484.22	778.66	204.25	504.44	5.16
Cash Acquisitions	-	-	-7.62	-	-	-14,602
Sale (Purchase) of Intangibles	-14,348	-12,330	-18,218	-8,322	-5,357	-7,603
Investment in Securities	3,048	6,083	-12,241	-893.53	-9,055	-16,256
Other Investing Activities	26,463	24,526	20,882	-47,331	1,520	562.08
Investing Cash Flow	-15,533	-11,417	-42,975	-68,267	-20,775	-41,615
Short-Term Debt Issued	-	33,669	60,421	20,081	300	27,069
Long-Term Debt Issued	-	29,608	42,000	22,000	3,352	45,920
Total Debt Issued	121,597	63,277	102,421	42,081	3,652	72,989
Short-Term Debt Repaid	-	-22,469	-45,000	-234.39	-468.76	-10,063
Long-Term Debt Repaid	-	-27,675	-42,958	-10,666	-10,062	-9,479
Total Debt Repaid	-123,289	-50,144	-87,958	-10,900	-10,530	-19,541
Net Debt Issued (Repaid)	-1,693	13,133	14,463	31,181	-6,878	53,448
Issuance of Common Stock	-	-	-	106.64	-	210.31
Repurchase of Common Stock	-	-	-	-	-6,171	-85.84
Dividends Paid	-6,430	-6,430	-6,359	-7,340	-4,120	-3,140
Other Financing Activities	-7,450	-7,632	-8,402	-4,434	-3,241	-1,906
Financing Cash Flow	-15,573	-929.26	-297.81	19,513	-20,411	48,527
Foreign Exchange Rate Adjustments	501.95	172.75	312.22	32.09	45.26	40.01
Miscellaneous Cash Flow Adjustments	-	-	-	-	-	1,893
Net Cash Flow	13,346	30,140	-12,926	3,013	-14,727	31,258
Free Cash Flow	13,152	12,512	-4,829	39,446	18,405	18,309
Free Cash Flow Growth	98.46%	-	-	114.32%	0.52%	34.58%
Free Cash Flow Margin	2.17%	2.07%	-0.81%	7.49%	3.84%	5.17%
Free Cash Flow Per Share	613.60	583.77	-226.83	1821.12	841.34	862.87
Cash Interest Paid	7,343	7,526	6,513	4,421	3,230	1,858
Cash Income Tax Paid	11,105	12,584	4,821	5,211	7,522	8,922
Levered Free Cash Flow	-16,945	11,631	-28,202	2,590	10,196	14,843
Unlevered Free Cash Flow	-12,469	16,144	-22,386	5,474	12,498	16,142
Change in Working Capital	21,825	18,365	-26,996	-4,611	-41,027	-16,784